Protease-activated receptor

Revision as of 19:16, 4 February 2014 by Gerald Chi (talk | contribs) (→‎Function)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
coagulation factor II (thrombin) receptor
Identifiers
SymbolF2R
Alt. symbolsPAR1
Entrez2149
HUGO3537
OMIM187930
RefSeqNM_001992
UniProtP25116
Other data
LocusChr. 5 q13
coagulation factor II (thrombin) receptor-like 1
Identifiers
SymbolF2RL1
Alt. symbolsPAR2, GPR11
Entrez2150
HUGO3538
OMIM600933
RefSeqNM_005242
UniProtP55085
Other data
LocusChr. 5 q13
coagulation factor II (thrombin) receptor-like 2
Identifiers
SymbolF2RL2
Alt. symbolsPAR3
Entrez2151
HUGO3539
OMIM601919
RefSeqNM_004101
UniProtO00254
Other data
LocusChr. 5 q13
coagulation factor II (thrombin) receptor-like 3
Identifiers
SymbolF2RL3
Alt. symbolsPAR4
Entrez9002
HUGO3540
OMIM602779
RefSeqNM_003950
UniProtQ96RI0
Other data
LocusChr. 19 p12

Protease-activated receptors are a subfamily of related G protein-coupled receptors that are activated by cleavage of part of their extracellular domain. They are highly expressed in platelets, but also on endothelial cells, myocytes and neurons.[1]

Classification

There are 4 known protease-activated receptors or PAR's, numbered from one to four. These receptors are members of the seven transmembrane G-protein-coupled receptor superfamily, and are expressed throughout the body.

Activation

PAR's are activated by the action of serine proteases such as thrombin (acts on PAR's 1, 3 and 4) and trypsin (PAR 2). These enzymes cleave the N-terminus of the receptor, which in turn acts as a tethered ligand. In the cleaved state, part of the receptor itself acts as the agonist, causing a physiological response.

Most of the PAR family act through the actions of G-proteins i (cAMP inhibitory), 12/13 (Raf/Ras activation) and q (calcium signalling) to cause cellular actions.

Function

The cellular effects of thrombin are mediated by protease-activated receptors (PARs). Thrombin signalling in platelets contributes to hemostasis and thrombosis. Endothelial PARs participate in the regulation of vascular tone and permeability while in vascular smooth muscle they mediate contraction, proliferation, and hypertrophy. PARs contribute to the pro-inflammatory response observed in atherosclerosis and restenosis. Recent research has also implicated these novel receptors in muscle growth and bone cell differentiation and proliferation.[2]

In T cells, activation of PAR1, PAR2 and PAR3 induce tyrosine phosphorylation of VAV1. Activation of PARs also led to an increase in tyrosine phosphorylation of ZAP-70 and SLP-76, two key proteins in T cell receptor (TCR) signalling.[3]

References

  1. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001). "Proteinase-activated receptors". Pharmacol Rev. 53 (2): 245–82. PMID 11356985.
  2. Martorell L, Martínez-González J, Rodríguez C, Gentile M, Calvayrac O, Badimon L (February 2008). "Thrombin and protease-activated receptors (PARs) in atherothrombosis". Thromb. Haemost. 99 (2): 305–15. doi:10.1160/TH07-08-0481. PMID 18278179.
  3. Bar-Shavit R, Maoz M, Yongjun Y, Groysman M, Dekel I, Katzav S (January 2002). "Signalling pathways induced by protease-activated receptors and integrins in T cells". Immunology. 105 (1): 35–46. doi:10.1046/j.0019-2805.2001.01351.x. PMC 1782632. PMID 11849313.

External links